The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Avenue Therapeutics Inc shares valued at $49,600 were sold by Davidow Robert L on Dec 11 ’23. At $0.14 per share, Davidow Robert L sold 353,000 shares. The insider’s holdings dropped to 22,000 shares worth approximately $2640.0 following the completion of this transaction.
Also, Davidow Robert L sold 264,000 shares, netting a total of over 36,960 in proceeds. Following the sale of shares at $0.14 each, the insider now holds 681,000 shares.
Before that, Fortress Biotech, Inc. had added 418,410 shares to its account. In a trade valued at $301,255, the 10% Owner bought Avenue Therapeutics Inc shares for $0.72 each. Upon closing the transaction, the insider’s holdings increased to 418,410 shares, worth approximately $0.12 million.
Analyzing ATXI Stock Performance
During the last five days, there has been a drop of approximately -13.08%. Over the course of the year, Avenue Therapeutics Inc shares have dropped approximately -27.33%. Shares of the company reached a 52-week high of $0.3529 on 01/04/24 and a 52-week low of $0.0852 on 04/25/24. A 50-day SMA is recorded $0.1490, while a 200-day SMA reached $0.4220. Nevertheless, trading volume fell to 10.11 million shares from 0.28 million shares the previous day.
Support And Resistance Levels for Avenue Therapeutics Inc (ATXI)
According to the 24-hour chart, there is a support level at 0.0948, which, if violated, would cause prices to drop to 0.0726. In the upper region, resistance lies at 0.1296. The next price resistance is at 0.1422. RSI (Relative Strength Index) is 39.96 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0176, which suggests the price will decrease in the coming days. Percent R is at 54.44%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
